clonazepam has been researched along with Neurodevelopmental Disorders in 1 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samarut, É | 1 |
| Swaminathan, A | 1 |
| Riché, R | 1 |
| Liao, M | 1 |
| Hassan-Abdi, R | 1 |
| Renault, S | 1 |
| Allard, M | 1 |
| Dufour, L | 1 |
| Cossette, P | 1 |
| Soussi-Yanicostas, N | 1 |
| Drapeau, P | 1 |
1 other study available for clonazepam and Neurodevelopmental Disorders
| Article | Year |
|---|---|
γ-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment.
Topics: Animals; Animals, Genetically Modified; Anticonvulsants; Brain; Clonazepam; Disease Models, Animal; | 2018 |